Press release
Global Personalized Cancer Vaccine Market Opportunity and Clinical Innovation Trend Outlook 2024
“Global Personalized Cancer Vaccine Market Opportunity and Clinical Innovation Trend Outlook 2024” Report Highlights:General Working Mechanism of Personalized Cancer Vaccine
Relevance of Biomarkers In Personalized Vaccines
Developmental Cost Analysis of a Personalized Cancer Vaccine
Advancements in the Personalized Cancer Vaccine
Personalized Cancer Vaccine Market Analysis by Cancer
Download Report:
https://www.kuickresearch.com/report-global-personalized-cancer-vaccine-market-opportunity-and-clinical-innovation-trend-outlook-2024.php
Report TOC
1. Personalized Cancer Vaccine: Promising Cancer Therapeutics of the Future
1.1 The Possibility of a Cancer Vaccine
1.2 Cancer Vaccines – An Insight into its Current Clinical Status
2. General Working Mechanism of Personalized Cancer Vaccine
2.1 Entities of A personalized Cancer Vaccine and Their Respective Roles
2.1.1 Tumor Neo – Antigens
2.1.2 Human Leukocyte Antigen
2.2 Personalized Cancer Vaccine in Action
2.3 Pharmacogenomics towards Genomic Polymorphism
2.4 Somatic Mutations in Cancer Pharmacogenomics
3. Relevance of Biomarkers In Personalized Vaccines
3.1 Pharmacogenomic Biomarkers
3.2 Prognostic and Predictive Biomarkers
3.3 Immune Checkpoint Biomarkers
4. Manufacturing Process and Cost Analysis of a Personalized Cancer Vaccine
4.1 Pre – Manufacturing Cost Analysis
4.2 Manufacturing Cost Analysis of Personalized Cancer Vaccine
4.2.1 Capital Cost
4.2.2 Cost of Raw Materials
4.2.3 Annual Cost of Personnel Involved in Cancer Vaccine Manufacture
4.2.4 Factory and Administrative Overheads
4.2.5 Filling and Packaging
4.3 Personalized Cancer Vaccine Cost per Patient
5. Current Market Trends and Advancements in the Personalized Cancer Vaccine Segment
5.1 Breakthrough Research Improving the Outcome of Future Personalized Cancer Vaccine
5.2 Rising Investments in the Personalized Cancer Vaccine Market
5.3 Use of mRNA for the Development of Personalized Cancer Vaccine
5.4 Collaborations and Ventures Ensure Stable Funding to the Personalized Cancer Vaccine Market
5.5 Advancement in DNA Sequencing Technology to Drive the Personalized Cancer Vaccine Market
6. Global – Personalized Cancer Vaccine Market Analysis by Cancer Type
6.1 Melanoma
6.2 Lung Cancer
6.3 Breast Cancer
6.4 Colorectal Cancer
6.5 Leukemia
6.6 Prostate Cancer
6.7 Cervical Cancer
6.8 Glioblastoma (Brain Tumor)
7. New Avenues and Opportunities for Personalized Cancer Vaccine Development
7.1 Commercial Insights into the Personalized Cancer Vaccine Pipeline
7.2 Opportunities in the Emerging Market
8. Porter’s Five Force Analysis of the Personalized Cancer Vaccine Market
8.1 Bargaining Power of Suppliers
8.2 Bargaining Power of Buyer
8.3 Threats of Substitute Products
8.4 Threat of New Entrants
8.5 Rivalry Among the Existing Competitors
9. Driving Factors of the Personalized Cancer Vaccine Market
9.1 Increasing Need for Personalized Cancer Vaccine Production
9.2 Alarming Increase in the Number of Cancer Incidences
9.3 Cancer Heterogenetic Environment
9.4 High Level of Specificity
9.5 Assistance from Government
9.6 Improvement in Genome Sequencing Techniques
9.7 Robust Clinical Pipeline Under Development
10. Major Challenges to the Personalized Cancer Vaccine Market
10.1 Scientific and Technical Challenges in Developing a Personalized Cancer Vaccine
10.2 Commercialization Challenges
11. Global Personalized Cancer Vaccine Market Future Outlook
12. Competitive Landscape
12.1 Advaxis Inc.
12.2 Avax Technologies
12.3 BioNtech AG
12.4 Celldex
12.5 CureVac AG
12.6 Genetech
12.7 Genocea
12.8 Gristone Oncology
12.9 ISA Pharmaceuticals
12.10 Merck
12.11 Moderna Therapeutics
12.12 Neon Therapeutics
12.13 Personalise
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
New Delhi – 110 001, India
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Personalized Cancer Vaccine Market Opportunity and Clinical Innovation Trend Outlook 2024 here
News-ID: 1453462 • Views: …
More Releases from KuicK Research

Multispecific Antibodies Clinical Trials By Indication Country Company Drug Clas …
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price and Clinical Trials Insight 2030 Report Highlights:
• Global Multispecific Antibodies Market Opportunity By 2030: > USD 50 Billion
• Global Multispecific Antibodies Market Sales In 2024: > USD 12 Billion
• Number Of Approved Multispecific Antibodies: 18
• Global and Regional Trends Insight
• Approved Antibodies Global, Regional, Annual and Quarterly Sales Insight
• Approved Antibodies Dosage and Pricing Insight
• Comprehensive Insight On All Antibodies In Clinical…

Gamma Delta T Cell Cancer Therapy Market Opportunity Clinical Trials Technology …
Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions:
• Number Of Gamma Delta T Cell Therapies In Trials: > 30 Therapies
• US & China Dominating Clinical Trials Landscape: > 20 Therapies
• Global Gamma Delta T Cell Therapy Clinical Trials Insight By Company, Country, Indication and Phase
• Gamma Delta T Cell Therapy Future Market Opportunity By Different Cancers
• Insight On Clinical Platforms for Evolving…

US Orphan Drugs Market Sales Clinical Trials Insight 2030
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030
• Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs
• Clinical Trials Insight By Company, Indication, Phase and Priority Status
• Insight On FDA Designated Marketed Orphan Drugs: > 500 Orphan Drugs
• Pricing and Dosage Insight: > 400 Marketed Orphan Drugs
• US, Global,…

US Orphan Drug Market Size Forecast 20230
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030
• Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs
• Clinical Trials Insight By Company, Indication, Phase and Priority Status
• Insight On FDA Designated Marketed Orphan Drugs: > 500 Orphan Drugs
• Pricing and Dosage Insight: >…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…